Upstart
UPST
$30.62
+7.21%
Upstart Holdings, Inc. operates an AI-powered lending platform that connects consumer loan demand with a network of bank partners, primarily in the unsecured personal and auto loan segments within the financial services industry. The company positions itself as a technology-driven disruptor, using proprietary artificial intelligence models to assess creditworthiness, aiming to expand access to credit beyond traditional FICO-based systems. The current investor narrative is dominated by a stark contrast between strong operational recovery in revenue and transaction volume and significant concerns over deteriorating profitability and the strategic risks associated with its plan to become a bank, creating a high-stakes debate around its long-term viability and growth trajectory.…
UPST
Upstart
$30.62
Related headlines
Investment Opinion: Should I buy UPST Today?
Rating & Thesis: Hold. Upstart presents a high-risk, high-potential-reward situation where severe operational challenges currently offset a deeply discounted valuation, warranting a neutral stance until profitability trends clarify. The mixed analyst sentiment, with recent upgrades countered by maintained underperform ratings, reflects this uncertainty, though a specific average target price is unavailable for anchoring.
Supporting Evidence: The primary valuation metric, a forward P/E of 8.41x, is exceptionally low and suggests the market is pricing in a near-quadrupling of earnings from the trailing EPS of $0.013. Revenue growth remains robust at 34.35% YoY. However, profitability is moving in the wrong direction, with net margin halving sequentially to 6.13%. Furthermore, negative free cash flow of -$166M and a high debt-to-equity ratio of 2.32 reveal financial strain. The stock trades at a Price-to-Sales of 3.90x, near its historical lows, indicating most growth optimism has been purged.
Risks & Conditions: The two biggest risks are the continued deterioration of net margins and the failure to generate positive free cash flow. This Hold rating would upgrade to a Buy if the company demonstrates two consecutive quarters of expanding net margins (e.g., above 8%) and provides a credible timeline to positive FCF. It would downgrade to a Sell if revenue growth decelerates below 20% YoY or if net income turns negative again. Relative to its own hyper-growth history, the stock is undervalued, but relative to its current fundamentals and cash burn, it appears fairly valued to slightly overvalued until execution improves.
Sign up to view all
UPST 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The valuation is compellingly cheap if the company can deliver on forward earnings, creating asymmetric upside potential. However, the recent quarterly deterioration in margins and persistent cash burn provide concrete evidence that execution risks are high and the path to justifying that multiple is fraught. The stock's fate hinges entirely on operational execution in the next two quarters. The stance would upgrade to bullish on confirmation of sustained margin expansion and a credible path to FCF positivity. It would turn bearish if the next earnings report shows further margin compression or a guidance cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Upstart's 12-month outlook, with a consensus price target around $39.81 and implied upside of +30.0% versus the current price.
Average Target
$39.81
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$25 - $40
Analyst target range
Analyst coverage is limited, with only 5 analysts providing estimates, indicating this is a stock with less institutional research scrutiny which can lead to higher volatility and less efficient price discovery. The consensus sentiment, inferred from recent institutional rating actions, appears mixed with recent upgrades (e.g., BTIG to Buy, Compass Point to Neutral) but also maintained underperform ratings, though a specific consensus recommendation and average target price are not provided in the data, preventing a calculation of implied upside/downside. The wide range in forward estimates signals high uncertainty; for example, the estimated EPS for the next period ranges from a low of $6.57 to a high of $7.10, a 8.1% spread, while revenue estimates range from $3.37 billion to $3.57 billion, a 6.2% spread; the high-end targets likely assume successful execution on growth and margin expansion, while the low-end may price in further operational missteps or macro headwinds.
Bulls vs Bears: UPST Investment Factors
The investment debate for Upstart is defined by a stark tension between compelling valuation metrics signaling deep value and severe fundamental cracks in profitability and cash flow. The bull case rests on the premise that the stock's dramatic de-rating—evidenced by a forward P/E of 8.4x and PS ratio near historical lows—has overly discounted a strong revenue recovery growing at 34% YoY. The bear case, currently supported by stronger evidence from recent quarterly results, points to a dangerous disconnect where growth is not translating into sustainable profits, as net margins collapsed sequentially and free cash flow remains deeply negative. The single most important factor that will resolve this thesis is whether management can arrest the margin deterioration and demonstrate a credible path to consistent, cash-generative profitability, thereby justifying the low forward multiple. Until then, the bearish evidence from operational execution outweighs the bullish argument from valuation alone.
Bullish
- Strong Revenue Recovery & Growth: Q4 2025 revenue grew 34.35% year-over-year to $304.17 million, demonstrating a robust operational recovery from the prior year's losses. This growth, while decelerating from peaks, confirms the underlying demand for its AI lending platform.
- Attractive Forward Valuation: The stock trades at a forward P/E of just 8.41x, based on analyst consensus EPS of $6.84, representing a significant discount to its own history and potentially to the sector. This low multiple prices in a dramatic earnings acceleration that, if achieved, offers substantial upside.
- Valuation Compression to Historical Lows: The current Price-to-Sales ratio of 3.90x is near the bottom of its observable historical range, down from highs above 130x in 2021. This suggests most hyper-growth optimism has been priced out, creating a potential value opportunity if the company stabilizes.
- Institutional Confidence Amidst Weakness: Recent news highlights a major fund, Hidden Lake, purchasing $13.8 million worth of shares, signaling institutional belief in the long-term AI disruption thesis despite the stock's 37.41% annual decline. This provides a counter-narrative to the prevailing negative sentiment.
Bearish
- Severe Profitability Deterioration: Despite revenue growth, Q4 2025 net income of $18.64 million fell sharply from $31.81 million in Q3, with the net margin halving from 11.12% to 6.13%. Gross margin also compressed over 600 basis points sequentially, signaling deep operational inefficiencies or rising costs.
- Persistent Negative Free Cash Flow: The company reported negative trailing twelve-month free cash flow of -$166.13 million, indicating it is burning cash to fund operations. With a debt-to-equity ratio of 2.32, this reliance on external financing or balance sheet cash ($1.06B) is a key sustainability risk.
- Technical Downtrend & Extreme Volatility: The stock is down 37.41% over the past year and trades near multi-year lows, underperforming the S&P 500 by over 65% in that period. With a beta of 2.26, it is 126% more volatile than the market, amplifying downside risk during sell-offs.
- Strategic Risk in Bank Charter Plan: Recent news highlights significant new risks tied to its plan to become a bank, including exposure to interest rate fluctuations and increased regulatory scrutiny. This strategic pivot adds complexity and uncertainty to its previously asset-light model.
UPST Technical Analysis
The stock is in a pronounced downtrend, having declined 37.41% over the past year, and is currently trading near the lower end of its 52-week range, at approximately 32.7% of the span between its 52-week low of $23.97 and high of $87.30. This positioning near multi-year lows suggests the market is pricing in significant fundamental challenges, presenting a potential value opportunity but with substantial 'catching a falling knife' risk given the persistent negative momentum. Recent short-term momentum shows severe weakness, with the stock down 17.79% over the past month and 2.49% over the past three months, significantly underperforming the S&P 500 which gained 4.84% and 8.15% over the same periods, respectively; this divergence from the broader market's strength underscores deep-seated, company-specific concerns overwhelming any macro tailwinds. Key technical levels are clear, with immediate resistance at the 52-week high of $87.30 and support at the 52-week low of $23.97; a breakdown below $23.97 would signal a new phase of capitulation, while any sustained move above the descending trendline would require a fundamental catalyst. The stock's extreme volatility is confirmed by a beta of 2.26, meaning it is approximately 126% more volatile than the market, which necessitates larger risk buffers for position sizing.
Beta
2.26
2.26x market volatility
Max Drawdown
-71.2%
Largest decline past year
52-Week Range
$24-$87
Price range past year
Annual Return
-32.3%
Cumulative gain past year
| Period | UPST Return | S&P 500 |
|---|---|---|
| 1m | -8.6% | +5.1% |
| 3m | +7.7% | +8.3% |
| 6m | -27.2% | +10.4% |
| 1y | -32.3% | +29.6% |
| ytd | -33.2% | +10.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
UPST Fundamental Analysis
Revenue growth has been robust but shows signs of sequential deceleration; Q4 2025 revenue was $304.17 million, representing a strong 34.35% year-over-year increase, yet this follows even higher growth rates in prior quarters of 2025 (Q3: 65.3% YoY, Q2: 90.5% YoY), indicating a normalization from peak recovery levels. Profitability is highly volatile and currently under pressure; while the company returned to net income of $18.64 million in Q4 2025 with a net margin of 6.13%, this represents a sharp decline from the Q3 2025 net income of $31.81 million and an 11.12% net margin, and the gross margin compressed to 90.81% from 96.92% in the prior quarter, signaling rising costs or a less favorable revenue mix. The balance sheet shows adequate liquidity with a current ratio of 2.99, but financial health is mixed with a high debt-to-equity ratio of 2.32 and negative trailing twelve-month free cash flow of -$166.13 million, indicating the company is consuming cash to fund operations and is dependent on external financing or balance sheet cash, which stood at $1.06 billion at the end of Q4 2025.
Quarterly Revenue
$304168000.0B
2025-12
Revenue YoY Growth
+0.34%
YoY Comparison
Gross Margin
+0.90%
Latest Quarter
Free Cash Flow
$-166132000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is UPST Overvalued?
Given the company's positive but volatile net income, we lead with the Price-to-Earnings (PE) ratio. The trailing PE is extremely high at 78.35x, while the forward PE is a much lower 8.41x, indicating the market expects a dramatic surge in earnings over the next twelve months to justify the current price. Compared to the Financial Services sector, Upstart's trailing PE of 78.35x represents a massive premium, though direct industry average data is not available in the provided set; the forward PE of 8.41x, however, would suggest a discount if sector averages are higher, highlighting the market's bet on a rapid earnings acceleration. Historically, the stock's own valuation has compressed dramatically from its peak; the current trailing PS ratio of 3.90x is near the bottom of its observable historical range from the provided data (which shows PS ratios as high as 132.90 in 2021), suggesting the market has already priced out most of the hyper-growth optimism, leaving the stock in a value zone contingent on a successful execution of its turnaround and profitability plans.
PE
78.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -515x~292x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
68.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are acute and center on profitability sustainability and cash burn. Despite a 34% YoY revenue increase in Q4 2025, net income fell 41% sequentially and the net margin compressed from 11.12% to 6.13%. The company is consuming cash, with TTM free cash flow at -$166.13 million, funded by a balance sheet holding $1.06 billion in cash but burdened by a high debt-to-equity ratio of 2.32. Revenue concentration in cyclical consumer lending (personal and auto loans) further exposes earnings to economic downturns and credit deterioration, making the projected earnings acceleration highly sensitive to macro conditions.
Market & Competitive Risks are heightened by the stock's extreme valuation compression and strategic pivot. Trading at a forward P/E of 8.4x implies the market expects massive earnings growth; any shortfall could trigger further multiple contraction. The beta of 2.26 confirms the stock's hyper-sensitivity to market swings, meaning it will likely fall harder than the market in a downturn. Competitively, established rivals are developing their own AI tools, potentially eroding Upstart's technological moe. The strategic risk of pursuing a bank charter, as noted in recent news, introduces interest rate risk and regulatory complexity that could strain its business model.
Worst-Case Scenario involves a perfect storm of execution failure and macro headwinds. This would entail a continued decline in loan demand, further gross margin compression below 85%, and a failure to achieve the analyst EPS estimates underpinning the 8.4x forward P/E. Coupled with a broader market sell-off, this could trigger a wave of analyst downgrades and a loss of institutional confidence. The realistic downside would be a retest and break below the 52-week low of $23.97, representing a potential loss of approximately -16% from the current price of $28.56. Given the stock's history of a -71.21% max drawdown, a decline of 30-40% in an adverse scenario is plausible if the profitability turnaround fails entirely.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: Net margin collapsed from 11.12% to 6.13% in one quarter; failure to stabilize and expand margins would invalidate the growth story. 2) Financial Health Risk: Persistent negative free cash flow (-$166M TTM) and high debt-to-equity (2.32) raise concerns about long-term sustainability without further dilution. 3) Execution & Strategic Risk: The plan to become a bank introduces new interest rate and regulatory risks, adding complexity to its model. 4) Market Risk: With a beta of 2.26, the stock is prone to severe declines during broader market downturns, independent of company-specific news.
The 12-month forecast is bifurcated with high uncertainty. The base case (50% probability) sees the stock trading between $35 and $50, as it meets consensus EPS estimates but fails to secure a higher multiple. The bull case (25% probability) targets $60 to $87, requiring successful execution on margins and a growth re-acceleration. The bear case (25% probability) warns of a drop to $23-$30, retesting the 52-week low if profitability further erodes. The most likely scenario is the base case, where the company muddles through with volatile but positive earnings, leaving the stock range-bound until a clearer trend emerges.
UPST's valuation presents a paradox. On a trailing basis, with a P/E of 78.35x and negative cash flow, it appears expensive. However, its forward P/E of 8.41x, based on analyst consensus EPS of $6.84, suggests it is deeply undervalued if those earnings materialize. Compared to its own history, its Price-to-Sales ratio of 3.90x is near multi-year lows, indicating a massive de-rating. The market is currently valuing the stock at a steep discount, implying extreme skepticism about its ability to achieve projected profitability. Therefore, it is fairly valued relative to current weak fundamentals but potentially undervalued relative to its future earnings potential—a bet entirely on successful execution.
UPST is a high-risk, high-potential-reward stock that is not a straightforward 'good buy' for most investors. For aggressive investors with a high risk tolerance and a long-term horizon, the current valuation (forward P/E of 8.4x) offers compelling upside if the company executes a profitability turnaround. However, the severe deterioration in net margins, negative free cash flow, and extreme stock volatility (beta of 2.26) present substantial downside risk. It could be a good buy for speculative capital only after confirming a reversal in operational trends, such as expanding net margins for two consecutive quarters.
UPST is unsuitable for short-term trading due to its extreme volatility (beta 2.26) and lack of near-term catalysts beyond unpredictable earnings reports. It is a speculative long-term investment for investors willing to hold for 3-5 years to see if its AI lending disruption thesis and profitability turnaround can be fully realized. The company pays no dividend and is in a capital-intensive growth phase, offering no income. Given the high uncertainty and binary outcome potential, a minimum holding period of 18-24 months is suggested to allow for several quarterly reports that can confirm or deny the turnaround trajectory.